Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reproducibility of 18F-EF5 PET in Head and Neck Cancer
NCT01774760Phase 2Completed
- Sponsor
- Turku University Hospital
- Start
- Mar 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorine F 18 EF5 in head and neck squamous cell carcinoma (HNSCC), sponsored by Turku University Hospital. Started Mar 2013; status: completed.
02
Drugs
fluorine F 18 EF5
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01774760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01774760.